Discrepancy of the effects of zinc supplementation on the prevention of radiotherapy-induced mucositis between patients with nasopharyngeal carcinoma and those with oral cancers: Subgroup analysis of a double-blind, randomized study

Nutrition and Cancer

Volumn 62, Issue 5, 2010, Pages 682-691

  Lin, Yung Song ^a   Lin, Li Ching ^a   Lin, Shih Wei ^b   Chang, Chun Ping ^c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c TAINAN UNIVERSITY OF TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CISPLATIN; CREATININE; PLACEBO; PRO-Z; TRANSFERRIN; UNCLASSIFIED DRUG; ZINC;

ADULT; ARTICLE; BETEL NUT; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASTICATION; MOUTH CANCER; MUCOSA INFLAMMATION; NASOPHARYNX CARCINOMA; PREMEDICATION; RADIATION DOSE; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; STANDARD; UREA NITROGEN BLOOD LEVEL; ZINC BLOOD LEVEL; AGED; DIET SUPPLEMENTATION; MIDDLE AGED; MOUTH NEOPLASMS; MUCOSITIS; NASOPHARYNGEAL NEOPLASMS; PROPORTIONAL HAZARDS MODEL;

ARECA;

ADULT; AGED; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MUCOSITIS; NASOPHARYNGEAL NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY; ZINC;

EID: 77953974709     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635581003605532     Document Type: Article

References (20)

1. Parsons J: The effect of radiation on normal tissues of the head and neck. In: Management of Head and Neck Cancer: A Multidisciplinary Approach, Million R and Cassisi N (eds.). Philadelphia: JB Lippincott Press, 1994, pp. 245-289.
2. Berger AM and Kilro TJ: Oral complications. In: Cancer: Principles and Practice of Oncology, De Vita V, Hellman S, and Rosenberg S (eds.), 5th ed. Philadelphia: Lippincott-Raven Press, 1997, pp. 2714-2725.
3. Sutherland SE and Browman GP: Prophylaxis of oral mucositis in irradiated head-and-neck cancer patients: a proposed classification scheme of interventions andmeta-analysis of randomized controlled trials. Int J Radiat Oncol Biol Phys 49, 917-930, 2001.
4. Ertekin MV, KoçM, Karslioglu I, and Sezen O: Zinc sulfate in the prevention of radiation-induced oropharyngeal mucositis: a prospective, placebocontrolled, randomized study. Int J Radiat Oncol Biol Phys 58, 167-174, 2004.
5. Douglas EP: Research advances in oral mucositis. Current Opin Oncol 1, 261-266, 1999.
6. Demorasi F, Bez C, and Carrassi A: Prevention and treatment of chemoand radiotherapy-induced oral mucositis. Minerva Stomatol 51, 173-186, 2002.
7. Worthington HV, Clarkson JE, and Eden OB: Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev 4, CD000978, 2007.
8. Lin LC, Que J, Lin LK, and Lin FC: Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head and neck cancers: a double-blind, randomized study. Int J Radiation Oncology Biol Phys 65, 745-750, 2006.
9. Maitra AK and Dorani B: Role of zinc in post-injury wound healing. Arch Emerg Med 9, 122-124, 1992.
10. Song MK, Rosenthal MJ,Naliboff BD, Phanumas L, andKangKW: Effects of bovine prostate powder on zinc, glucose, and insulin metabolism in old patients with non-insulin-dependent diabetes mellitus. Metabolism 47, 39-43, 1998.
11. Nielsen NH, Mikkelsen F, andHansen JP: Nasopharyngeal cancer in Greenland: the incidence in an Arctic Eskimo population. Acta Pathol Microbiol Scand 85, 850-858, 1977.
12. KannanV, Bapsy PP, AnanthaN,Doval DC,Vaithianthan H, et al.: Efficacy and safety of granulocytemacrophage-colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with headand- neck carcinoma. Int J Radiat Oncol Biol Phys 37, 1005-1010, 1997.
13. Dörr W, Hamilton CS, Boyd T, Reed B, and Denham JW: Radiationinduced changes in cellularity and proliferation in human oral mucosa. Int J Radiat Oncol Biol Phys 52, 911-917, 2002.
14. Herrstedt J: Prevention and management of mucositis in patients with cancer. Int J Antimicrob Agents 16, 161-163, 2000.
15. SabithaKE and ShyamaladeviCS: Oxidant and antioxidant activity changes in patients with oral cancer and treated with radiotherapy. Oral Oncol 35, 273-277, 1999.
16. Chung CH, Yang YH, Wang TY, and Shieh TY: Warnakulasuriya S. Oral precancerous disorders associated with areca quid chewing, smoking, and alcohol drinking in southern Taiwan. J Oral Pathol Med 34, 460-466, 2005.
17. Wang CC, Liu TY, Wey SP, Wang FI, and Jan TR: Areca nut extract suppresses T-cell activation and interferon-gamma production via the induction of oxidative stress. Food Chem Toxicol 45, 1410-1418, 2007.
18. Trivedy CR,Warnakulasuriya KA, Peters TJ, Senkus R, Hazarey VK, et al.: Raised tissue copper levels in oral submucous fibrosis. J Oral Pathol Med 29, 241-248, 2000.
19. TilakaratneWM, KlinikowskiMF, Saku T, Peters TJ, andWarnakulasuriya S: Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol 42, 561-568, 2006.
20. Rajendran R and Karunakaran A: Further on the causation of oral submucous fibrosis. Indian J Dent Res 13, 74-81, 2002.